Healio: FDA expands Klisyri approval for actinic keratosis treatment on larger face, scalp areas FDA expands Klisyri approval for actinic keratosis treatment on larger face, scalp areas Newly published data confirm that daily topical tirbanibulin (Klisyri) was effective at treating actinic keratosis lesions on the face and scalp in two phase III trials. In two identical double-blind ... Business Insider: Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp First-in-class microtubule inhibitor indicated for the topical treatment of actinic keratosis (AK) on the face or scalp with a 5-day application course Klisyri will be manufactured by Athenex Almirall ...

Context Explanation

Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp Tirbanibulin ointment 1% shows good safety and tolerability in the treatment of actinic keratosis (AK) in fields of up to 100 cm 2 on the face and scalp. The most common local effects of treatment ... MedPage Today: Want Data on Recently Approved Actinic Keratosis Drug? Here You Go